Loading
Latest filing published 03 Apr 2026 for 셀트리온제약, €55.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 이언형 in 셀트리온제약, where the filings describe the role as board member. Between 26 March 2024 and 24 March 2026, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases worth €231 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2026: 1 purchase and no sales on the market.
The newest entry dates from 3 April 2026: an open-market purchase of €55, in 셀트리온제약. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.